Kangji Medical Holdings Limited (HKG:9997)

Kangji Medical Holdings Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1,009	926.02	786.37	690.26	511.49
Revenue Growth (YoY)	8.92%	17.76%	13.92%	34.95%	1.59%
Cost of Revenue	210.96	184.82	151.12	127.34	80.02
Gross Profit	797.65	741.2	635.25	562.93	431.47
Selling, General & Admin	175.53	170.11	124.64	108.58	94.58
Research & Development	82.08	127.55	66.02	36	25.22
Operating Expenses	257.33	298.73	189.61	145.19	119.8
Operating Income	540.32	442.47	445.64	417.74	311.67
Interest Expense	-0.64	-2.26	-1.88	-0.2	-0.04
Interest & Investment Income	92.13	91.89	70	51.59	17.14
Earnings From Equity Investments	-21.86	-	-	-	-
Currency Exchange Gain (Loss)	-12.98	-3.1	-3.2	3.12	-25.04
Other Non Operating Income (Expenses)	55.37	54.16	53.15	30.78	35.82
EBT Excluding Unusual Items	652.34	583.16	563.72	503.02	339.55
Gain (Loss) on Sale of Investments	5.24	5.56	-0.76	31.6	2.94
Gain (Loss) on Sale of Assets	27.25	0.05	0.19	-0.12	-0.1
Other Unusual Items	-	-	-	-	-32.31
Pretax Income	684.83	588.77	563.14	534.5	310.08
Income Tax Expense	113.56	136.48	101.97	77.71	50.93
Earnings From Continuing Operations	571.28	452.3	461.17	456.79	259.15
Minority Interest in Earnings	10.16	51.73	17.56	-	-8.85
Net Income	581.44	504.02	478.74	456.79	250.3
Net Income to Common	581.44	504.02	478.74	456.79	250.3
Net Income Growth	15.36%	5.28%	4.80%	82.50%	21.24%
Shares Outstanding (Basic)	1,176	1,170	1,208	1,224	953
Shares Outstanding (Diluted)	1,176	1,172	1,208	1,232	964
Shares Change (YoY)	0.29%	-2.95%	-1.95%	27.83%	-6.13%
EPS (Basic)	0.49	0.43	0.40	0.37	0.26
EPS (Diluted)	0.49	0.43	0.40	0.37	0.26
EPS Growth	15.03%	8.48%	6.88%	42.78%	29.16%
Free Cash Flow	504.81	332.79	243.62	404.88	203.21
Free Cash Flow Per Share	0.43	0.28	0.20	0.33	0.21
Dividend Per Share	0.240	0.410	0.184	0.140	0.037
Dividend Growth	-41.46%	122.22%	31.44%	278.86%	-
Gross Margin	79.08%	80.04%	80.78%	81.55%	84.36%
Operating Margin	53.57%	47.78%	56.67%	60.52%	60.93%
Profit Margin	57.65%	54.43%	60.88%	66.18%	48.94%
Free Cash Flow Margin	50.05%	35.94%	30.98%	58.66%	39.73%
EBITDA	562.61	464.58	460.32	427.25	319.14
EBITDA Margin	55.78%	50.17%	58.54%	61.90%	62.40%
D&A For EBITDA	22.3	22.11	14.68	9.52	7.47
EBIT	540.32	442.47	445.64	417.74	311.67
EBIT Margin	53.57%	47.78%	56.67%	60.52%	60.93%
Effective Tax Rate	16.58%	23.18%	18.11%	14.54%	16.42%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.